Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT)
CUSIP: 359664109
Q4 2016 13F Holders as of 31 Dec 2016
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 28,846,139
- Total 13F shares
- 3,066,506
- Share change
- +418,780
- Total reported value
- $35,477,491
- Price per share
- $11.57
- Number of holders
- 36
- Value change
- +$5,733,496
- Number of buys
- 28
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 359664109?
CUSIP 359664109 identifies FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 359664109:
Top shareholders of FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP |
13F
|
Company |
2.8%
|
800,000
|
$7,376,000 | — | 30 Sep 2016 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.1%
|
603,400
|
$5,563,000 | — | 30 Sep 2016 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
1.3%
|
370,300
|
$3,414,000 | — | 30 Sep 2016 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.52%
|
150,000
|
$1,383,000 | — | 30 Sep 2016 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.43%
|
125,000
|
$1,153,000 | — | 30 Sep 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.31%
|
88,514
|
$816,000 | — | 30 Sep 2016 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.28%
|
80,000
|
$738,000 | — | 30 Sep 2016 | |
| Nationwide Fund Advisors |
13F
|
Company |
0.25%
|
72,855
|
$672,000 | — | 30 Sep 2016 | |
| Laurion Capital Management LP |
13F
|
Company |
0.1%
|
30,000
|
$277,000 | — | 30 Sep 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.07%
|
21,000
|
$194,000 | — | 30 Sep 2016 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.03%
|
10,000
|
$92,000 | — | 30 Sep 2016 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.03%
|
8,334
|
$77,000 | — | 30 Sep 2016 | |
| Point72 Hong Kong Ltd |
13F
|
Company |
0.02%
|
7,200
|
$66,000 | — | 30 Sep 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
500
|
$5,000 | — | 30 Sep 2016 | |
| Catalyst Capital Advisors LLC |
13F
|
Company |
0%
|
358
|
$3,000 | — | 30 Sep 2016 |
Institutional Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q4 2016
As of 31 Dec 2016,
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,066,506 shares.
The largest 10 holders included
Cormorant Asset Management, LLC, WELLINGTON MANAGEMENT GROUP LLP, PUTNAM INVESTMENTS LLC, VANGUARD GROUP INC, SCHOLTZ & COMPANY, LLC, BAKER BROS. ADVISORS LP, Alyeska Investment Group, L.P., GRANAHAN INVESTMENT MANAGEMENT INC/MA, Nationwide Fund Advisors, and UNITED SERVICES AUTOMOBILE ASSOCIATION.
This page lists
36
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2016 vs Q3 2016 Across Filers
Q3 2016 holders
16
Q4 2016 holders
36
Holder diff
20
| Investor | Q3 2016 Shares | Q4 2016 Shares | Share Diff | Share Chg % | Q3 2016 Value $ | Q4 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.